U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday th...
WASHINGTON - U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how the agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.
Unlike his predecessors, who said drug pricing was not the purview of the FDA, Gottlieb waded into the intensifying debate about the high cost of medicines for U.S. consumers and had the agency actively looking into possible solutions. On Monday, he confronted 15 retailers including Walgreens Boots Alliance, Kroger Co and Walmart Inc, for illegally selling tobacco products to children. In early February, the FDA pursued enforcement actions against some Walgreen and Circle K locations.
“He made proposals that were unprecedented in their breadth, scope and, if they were adopted, likely impact,” said Matthew Myers, president of the Campaign for Tobacco-Free Kids. “But they were just proposals.”Gottlieb’s campaign against flavored e-cigarettes followed preliminary federal data showing teenage use had surged by more than 75 percent since last year, which the FDA described as an “epidemic.
Trump picked Gottlieb to lead the agency in March 2017 and he was confirmed by the Senate in May of that year.“There’s perhaps nothing that could pull me away from this role other than the challenge of being apart from my family for these past two years,” Gottlieb wrote in a note to FDA staff. He surprised critics who worried about his ties to the pharmaceutical industry by speaking out about rising drug prices and drug company tactics to keep competitors off the market.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA Commissioner Scott Gottlieb just resigned as head of the US's top food and drug regulatorGottlieb worked in the healthcare industry before joining the Food and Drug Administration as its top official during the Trump administration.
Weiterlesen »
FDA Commissioner Scott Gottlieb resignsFood and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency’s response to a host of public health challenges, including the opioid epidemic, rising drug prices and underage vaping.
Weiterlesen »
FDA Commissioner Scott Gottlieb resignsFood and Drug Administration Commissioner Scott Gottlieb has resigned and plans to leave the agency in a month.
Weiterlesen »
FDA finds asbestos in three products sold by Claire'sThe FDA calls on Congress to modernize cosmetics safety rules after issuing an alert about asbestos contamination detected in three products sold by retailer Claire's
Weiterlesen »
FDA's Gottlieb To Resign Amid Opioid Crisis And Crackdown On Retail Youth Tobacco SalesFDA Commissioner Dr. Scott Gottlieb to resign amid opioid crisis and crackdown on retail youth tobacco sales
Weiterlesen »
FDA's Gottlieb To Resign Amid Opioid Crisis And Crackdown On Retail Youth Tobacco SalesFood and Drug Administrator Dr. Scott Gottlieb will resign, the Trump administration confirmed Tuesday.
Weiterlesen »
FDA warns Canadian drug distributor about sending ‘unsafe’ drugs to U.S.A CanaRx representative said he was baffled by the action, saying it facilitates sales of “American brand-name drugs only.”
Weiterlesen »
Senator Sanders urges FDA to allow older versions of $375K drugU.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and m...
Weiterlesen »
U.S. Senator Sanders urges FDA to allow older versions of $375,000 drugU.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and m...
Weiterlesen »